EUVIMEDEUVIMED entdecken
VergleichsstudieValidierungsstudieOpen Access · CC BY 4.0

Novel validation of HDR brachytherapy dosimetry for cervical cancer using egs_brachy Monte Carlo simulations: a comparative analysis with Oncentra treatment planning system

Duong Thanh Tai iD, Nguyen Thi Anh Thu, Tran Thien Thanh iD, Pham Anh Tuan, Marc J P Chamberland, Peter Sandwall iD, David Bradley iD, James C L Chow iD

Journal of Applied Clinical Medical Physics · 2025

DOI: 10.1002/acm2.70144 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Applied Clinical Medical Physics, 2025. Verfasst von Duong Thanh Tai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Faculty of Medicine, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Monte Carlo Method, Radiotherapy Planning, Computer-Assisted, Brachytherapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aims to validate HDR brachytherapy dosimetry for cervical cancer patients utilizing the egs_brachy Monte Carlo (MC) simulation.

Methods

Three cervical cancer patients treated with 192 Ir HDR brachytherapy were included. Dose distributions were calculated by the Oncentra Brachy v4 treatment planning system (TPS) based on AAPM TG‐43. The newly developed eb_gui, an egs_brachy graphical user interface for MC simulations, was applied in recalculating dose distributions for 12 fractions using digital imaging and communications in medicine‐radiotherapy (DICOM‐RT) anatomical information. Comparisons were made for clinical target volume (CTV), bladder, and rectum using dose–volume histograms (DVH) and clinically relevant plan quality indices.

Results

TPS‐calculated doses were greater than those obtained from MC simulations. For the CTV, the median percentage differences were 7.9% (Q1: 6.4%, Q3: 9.8%; range: 0.4%–10.4%) for D 90 . For the bladder, the median percentage differences were 0.7% (Q1: 0.4%, Q3: 2.3%; range: −9.4–5.4%) for D 2cc . For the rectum, the median percentage differences were 3.6% (Q1: 2.8%, Q3: 5.6%; range: 0.9%–6.4%) for D 2cc .

Conclusion

CTV and critical organ doses calculated by the TPS were consistently greater than those obtained from MC simulations. This suggests that the TPS may overestimate dose distributions, especially in heterogeneous regions like the pelvis. These results emphasize the need for continued validation of TPS algorithms in HDR brachytherapy for cervical cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsMonte Carlo MethodRadiotherapy Planning, Computer-AssistedBrachytherapyOrgans at RiskIridium RadioisotopesHumansRadiotherapy DosageFemaleRadiotherapy, Intensity-ModulatedRadiometry

Stichwörter der Autor:innen

Monte Carlo simulationTG‐186TG‐43brachytherapydose calculationsegs_brachyheterogeneityradiation treatment planning

Substanzen

Iridium RadioisotopesIridium-192

Autor:innen und Institutionen

  • Department of Medical Physics, Faculty of Medicine, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam.
  • Department of Nuclear Physics, Faculty of Physics and Engineering Physics, University of Science, Ho Chi Minh City, Vietnam.
  • Vietnam National University, Ho Chi Minh City, Vietnam.
  • Nuclear Medicine and Oncology Centre, Bach Mai Hospital, Ha Noi, Vietnam.
  • Department of Radiation Oncology, University of Vermont Medical Center, Vermont, USA.
  • Department of Radiation Oncology OhioHealth Mansfield, Ohio, USA.

ORCID-Profile: Duong Thanh Tai, Tran Thien Thanh, Peter Sandwall, David Bradley, James C L Chow

Zitieren

APA

Tai, D. T., Thu, N. T. A., Thanh, T. T., Tuan, P. A., Chamberland, M. J. P., Sandwall, P., Bradley, D., & Chow, J. C. L. (2025). Novel validation of HDR brachytherapy dosimetry for cervical cancer using egs_brachy Monte Carlo simulations: a comparative analysis with Oncentra treatment planning system. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70144

Vancouver

Tai DT, Thu NTA, Thanh TT, Tuan PA, Chamberland MJP, Sandwall P, et al. Novel validation of HDR brachytherapy dosimetry for cervical cancer using egs_brachy Monte Carlo simulations: a comparative analysis with Oncentra treatment planning system. Journal of Applied Clinical Medical Physics. 2025. doi:10.1002/acm2.70144

BibTeX
@article{Tai2025,
  author = {Tai, Duong Thanh and Thu, Nguyen Thi Anh and Thanh, Tran Thien and Tuan, Pham Anh and Chamberland, Marc J P and Sandwall, Peter and Bradley, David and Chow, James C L},
  title = {Novel validation of HDR brachytherapy dosimetry for cervical cancer using egs_brachy Monte Carlo simulations: a comparative analysis with Oncentra treatment planning system},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2025},
  doi = {10.1002/acm2.70144}
}
Kostenlos starten →